Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 9, 2014, Pages 1170-1178

  Arnold, M ^a   Holterhues, C ^a   Hollestein, L M ^a   Coebergh, J W W ^a,b   Nijsten, T ^a   Pukkala, E ^c,d   Holleczek, B ^e   Tryggvadottir L ^f,g   Comber, H ^h   Bento, M J ⁱ   Diba, Ch S ^j   Micallef, R ^k   Primic Zakelj M ^l   Izarzugaza, M I ^m   Perucha, J ⁿ   Marcos Gragera, R ^o   Galceran, J ^p   Ardanaz, E ^q,r   Schaffar, R ^s   Pring, A ^t   De Vries, E ^a,b   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b The Netherlands   (Netherlands)

^c FINNISH CANCER REGISTRY   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e Saarland Cancer Registry   (Germany)

^f ICELANDIC CANCER REGISTRY   (Iceland)

^g UNIVERSITY OF ICELAND   (Iceland)

^h NATIONAL CANCER REGISTRY IRELAND   (Ireland)

ⁱ PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^j CANCER RESEARCH INSTITUTE   (Slovakia)

^k Malta National Cancer Registry   (Malta)

^l INSTITUTE OF ONCOLOGY   (Slovenia)

^m Basque Cancer Registry   (Spain)

ⁿ Servicio de Epidemiologia y Prevencion Sanitaria   (Spain)

^o CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^p INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^q INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^r CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^s GENEVA CANCER REGISTRY   (Switzerland)

^t PUBLIC HEALTH ENGLAND   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CUTANEOUS MELANOMA; EASTERN EUROPE; EUROPE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NORTHERN EUROPEAN; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOUTHERN EUROPE; WESTERN EUROPE; FORECASTING; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; TIME;

ADULT; AGED; EUROPE; FEMALE; FORECASTING; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME FACTORS;

EID: 84906933783     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12236     Document Type: Article

References (35)

1. Miller AJ, Mihm MC,. Jr. Melanoma. N Engl J Med 2006; 355: 51-65.
2. Holterhues C, Vries E, Louwman MW, Koljenovic S, Nijsten T,. Incidence and trends of cutaneous malignancies in The Netherlands, 1989-2005. J Invest Dermatol 2010; 130: 1807-1812.
3. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW,. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345-1389.
4. de Vries E, Bray FI, Coebergh JW, Parkin DM,. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003; 107: 119-126.
5. Erdmann F, Lortet-Tieulent J, Schuz J, et al,. International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer 2013; 132: 385-400.
6. Forsea AM, Del Marmol V, de Vries E, Bailey EE, Geller AC,. Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol 2012; 167: 1124-1130.
7. Gandini S, Sera F, Cattaruzza MS, et al,. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 41: 2040-2059.
8. Gandini S, Sera F, Cattaruzza MS, et al,. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45-60.
9. Gandini S, Sera F, Cattaruzza MS, et al,. Meta-analysis of risk factors for cutaneous melanoma: I Common and atypical naevi. Eur J Cancer 2005; 41: 28-44.
10. Parkin DM, Muir CS,. Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ 1992; 120: 45-173.
11. Parkin DM, Muir CS, Whelan JS, Gao YT, Ferlay J, Powelly. Cancer incidence in five continents. Vol. VI, IARC scientific publications, Lyon, France, 1992.
12. Kim HJ, Fay MP, Feuer EJ, Midthune DN,. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.
13. Dyba T, Hakulinen T,. Comparison of different approaches to incidence prediction based on simple interpolation techniques. Stat Med 2000; 19: 1741-1752.
14. Dyba T, Hakulinen T, Paivarinta L,. A simple non-linear model in incidence prediction. Stat Med 1997; 16: 2297-2309.
15. Association of the Nordic Cancer Registries. Danish Cancer Society. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 5.2 (December 2012) [database on the Internet]. 2012. URL http://www.dep.iarc.fr/nordcan.htm. (last accessed: 06 February 2013).
16. Integraal Kankercentrum Nederland. Cijfers over kanker. [database on the Internet] 2013. URL www.cijfersoverkanker.nl.
17. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al,. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-1403.
18. Znaor A, van den Hurk C, Primic-Zakelj M, et al,. Cancer incidence and mortality patterns in South Eastern Europe in the last decade: gaps persist compared with the rest of Europe. Eur J Cancer 2013; 49: 1683-1691.
19. Gondos A, Bray F, Hakulinen T, Brenner H,. Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis. Ann Oncol 2009; 20: 564-573.
20. Ferlay J, Parkin DM, Steliarova-Foucher E,. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46: 765-781.
21. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917.
22. La Vecchia C, Lucchini F, Negri E, Levi F,. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 1999; 81: 62-66.
23. Hollestein LM, van den Akker SA, Nijsten T, Karim-Kos HE, Coebergh JW, de Vries E,. Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989. Ann Oncol 2012; 23: 524-530.
24. Aceituno-Madera P, Buendia-Eisman A, Arias-Santiago S, Serrano-Ortega S,. [Changes in the incidence of skin cancer between 1978 and 2002] Evolucion de la incidencia del cancer de piel en el periodo 1978-2002. Actas Dermosifiliogr 2010; 101: 39-46.
25. Cicarma E, Juzeniene A, Porojnicu AC, Bruland OS, Moan J,. Latitude gradient for melanoma incidence by anatomic site and gender in Norway 1966-2007. J Photochem Photobiol, B 2010; 101: 174-178.
26. Crocetti E, Carli P, Miccinesi G,. Melanoma incidence in central Italy will go on increasing also in the near future: a registry-based, age-period-cohort analysis. Eur J Cancer Prev 2007; 16: 50-54.
27. de Vries E, Coebergh JW,. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004; 40: 2355-2366.
28. Fuglede NB, Brinck-Claussen UO, Deltour I, Boesen EH, Dalton SO, Johansen C,. Incidence of cutaneous malignant melanoma in Denmark, 1978-2007. Br J Dermatol 2011; 165: 349-353.
29. Juzeniene A, Micu E, Porojnicu AC, Moan J,. Malignant melanomas on head/neck and foot: differences in time and latitudinal trends in Norway. J Eur Acad Dermatol Venereol 2012; 26: 821-827.
30. Stang A, Pukkala E, Sankila R, Soderman B, Hakulinen T,. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases. Int J Cancer 2006; 119: 380-384.
31. Marcos-Gragera R, Vilar-Coromina N, Galceran J, et al,. Rising trends in incidence of cutaneous malignant melanoma and their future projections in Catalonia, Spain: increasing impact or future epidemic? J Eur Acad Dermatol Venereol 2010; 24: 1083-1088.
32. Katalinic A, Kunze U, Schafer T,. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003; 149: 1200-1206.
33. Waldmann A, Nolte S, Weinstock MA, et al,. Skin cancer screening participation and impact on melanoma incidence in Germany-an observational study on incidence trends in regions with and without population-based screening. Br J Cancer 2012; 106: 970-974.
34. de Vries E, Arnold M, Altsitsiadis E, et al,. Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010-2050. Br J Dermatol 2012; 167 (Suppl 2): 53-62.
35. Breitbart EW, Waldmann A, Nolte S, et al,. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012; 66: 201-211.